Blog
CareDx v. Natera – The Broad Road to Patent Ineligibility
Blog
Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal
Blog
Novartis v. Accord Redux – Panel 2 Reverses Panel 1
Blog
The Solicitor’s Holistic Approach to the Mayo/Alice Analysis in American Axle
Blog
Almirall v. Amneal Pharmaceuticals – Negative Limitations II
Blog
Intellectual Property in Russia
Blog
Qualcomm v. Apple – Pyrrhic Victory for Qualcomm?
Blog
Novartis v. Accord – No Limits on Negative Limitations?
Blog
Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement?
Blog
Indivior v. Dr. Reddy’s Laboratory – Homeless on the Range
Blog
Strathclyde v. Clear-Vu – A Class in Obviousness
Blog